| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/06/2007 | US7186822 Process for the synthesis of oligomeric compounds |
| 03/06/2007 | US7186815 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from Lactococcus lactis |
| 03/06/2007 | US7186814 Bioconjugate-nanoparticle probes |
| 03/06/2007 | US7186813 Biomolecules having multiple attachment moieties for binding to a substrate surface |
| 03/06/2007 | US7186804 IL-2 fusion proteins with modulated selectivity |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186747 enzyme inhibitors comprising heterocyclic amides, used for prevention of viral diseases |
| 03/06/2007 | US7186696 Kit which uses maltose and chromogens to quantify hydrolase activity and diagnose pancreatic, kidney, liver or tumor disorders |
| 03/06/2007 | US7186568 Electrochemiluminescence from acridan compounds |
| 03/06/2007 | US7186565 Sampling and toxicity monitoring device and method |
| 03/06/2007 | US7186553 Human derived immortalized liver cell line |
| 03/06/2007 | US7186537 Human GAK-related gene variants associated with lung cancer |
| 03/06/2007 | US7186534 Screening for predisposition to cancer, screening for enzyme inhibitors |
| 03/06/2007 | US7186530 Stress-phosphorylated endoplasmic reticulum protein, Nogo B, for therapy |
| 03/06/2007 | US7186527 Goodpasture antigen binding protein |
| 03/06/2007 | US7186521 Determining the effect of a substance on sequestration, uptake, and accumulation of amyloid in brain cells |
| 03/06/2007 | US7186520 Substrate for assaying ribonuclease H activity |
| 03/06/2007 | US7186519 Using labeled c theta complex in permeabilized cells to detect and monitor cholesterol accumulation; diagnosing neurodegenerative diseases; drug screening |
| 03/06/2007 | US7186516 Methods of detecting specific cell lysis |
| 03/06/2007 | US7186514 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 03/06/2007 | US7186513 Methods for monitoring multiple gene expression |
| 03/06/2007 | US7186512 Methods and compositions for determining methylation profiles |
| 03/06/2007 | US7186511 Oxidase |
| 03/06/2007 | US7186510 Evaluating a uniformity of spots on a DNA microarray having a plurality of spots, these spots undergoing specific emissions as a result of hybridization of target DNA and tagged probe DNA, by examining whether patterns having periodicity are manifested in a sequence BG comprising background data obtained |
| 03/06/2007 | US7186509 Detection of a genetic predisposition to cancers in cats |
| 03/06/2007 | US7186508 Contacting the sample solution with a dipstick to cause sample solution to move by capillary action to a capture zone of the dipstick thereby allowing target nucleic acid in the sample solution to be captured and detected at the capture zone |
| 03/06/2007 | US7186507 Fluorescent in situ RT-PCR |
| 03/06/2007 | US7186506 Assessing the effectiveness of a candidate HIV antiretroviral compound by culturing a host cell in the presence of candidate HIV antiretroviral compound; host cell is a test vector of a nucleic acid segment encoding HIV protease with a mutation at codon 88 and an indicator gene |
| 03/06/2007 | US7186505 When expressed in a cell, the expression system provides a level of expression of a reporter molecule in cell which is indicative of regulation of the transduction pathway by a specific polypeptide of a plurality of polypeptides expressed by the cell. |
| 03/06/2007 | US7186504 Cells for detection of enteroviruses |
| 03/06/2007 | US7186503 Compounds and methods for modulating activation of NF-κB |
| 03/06/2007 | US7186502 Process for preparing control samples of particles such as microorganisms and cells |
| 03/06/2007 | US7186398 Fe/Au nanoparticles and methods |
| 03/06/2007 | US7186377 Absorption power measuring device |
| 03/06/2007 | CA2559880A1 Knock-out animal for taar1 function |
| 03/06/2007 | CA2324413C Device and methods for single step collection and assaying of biological fluids |
| 03/06/2007 | CA2218641C Diaminofluorescein derivative |
| 03/01/2007 | WO2007025281A2 A method to quantify sirnas, mirnas and polymorphic mirnas |
| 03/01/2007 | WO2007025269A2 Transgenic mouse model and methods for treatment of neuro muscular disease by interfering with androgen-androgen receptor interaction in skeletal muscles |
| 03/01/2007 | WO2007025231A2 Methods using snail transcriptional repressor |
| 03/01/2007 | WO2007025205A2 Systems and methods for identifying functional dna codes of condition-specific common cis-regulatory motifs and modules and their corresponding transcription factors |
| 03/01/2007 | WO2007025124A1 Single molecule sequencing of captured nucleic acids |
| 03/01/2007 | WO2007025097A2 Use |
| 03/01/2007 | WO2007025085A2 Genemap of the human genes associated with crohn's disease |
| 03/01/2007 | WO2007025079A2 Detection of mutations in a gene associated with resistance to viral infection, oas2 or oas3 |
| 03/01/2007 | WO2007025044A2 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| 03/01/2007 | WO2007025008A2 Translation enhancer-element dependent vector systems |
| 03/01/2007 | WO2007024960A2 Assays, methods and compositions that exploit a mycobacterial iron acquisition pathway in cells |
| 03/01/2007 | WO2007024840A2 Method of quantitating nucleic acids by flow cytometry microparticle-based array |
| 03/01/2007 | WO2007024808A2 Indicator polynucleotide controls |
| 03/01/2007 | WO2007024706A1 Detecting pathogens in companion animals |
| 03/01/2007 | WO2007024701A2 Microfluidic methods for diagnostics and cellular analysis |
| 03/01/2007 | WO2007024676A2 Methods for preparing hybrid substrates comprising dna and antibodies and uses thereof |
| 03/01/2007 | WO2007024653A2 Method and substances for isolating micro rnas |
| 03/01/2007 | WO2007024295A2 Capture and random amplification protocol for identification and monitoring of microbial diversity |
| 03/01/2007 | WO2007023915A1 Imprint polymer and use thereof |
| 03/01/2007 | WO2007023903A1 Method for predicting carcinogenicity of test substance |
| 03/01/2007 | WO2007023808A1 Skin aging marker and technique for use thereof |
| 03/01/2007 | WO2007023461A2 Method for detection of micro-organisms and antibiotic resistance markers and nucleic acid oligonucleotides therefor |
| 03/01/2007 | WO2007023306A1 Diagnostic assay and therapeutic treatment for bone disorders (osteoporosis) |
| 03/01/2007 | WO2007023282A1 Use of holographic sensor |
| 03/01/2007 | WO2007023190A2 Genes involved in asymmetric cell division |
| 03/01/2007 | WO2007023185A1 Detection of salmonella lactose+ |
| 03/01/2007 | WO2007023181A1 Method for the separation of living cells |
| 03/01/2007 | WO2007023148A2 Nucleic acid variants in the lbp gene associated with altered innate immunity |
| 03/01/2007 | WO2007022590A1 Identification of ancestral haplotypes and uses thereof |
| 03/01/2007 | WO2007022588A1 Method for assessing a response to an antiproliferative agent |
| 03/01/2007 | WO2007009094A3 Antisense antibacterial method and compound |
| 03/01/2007 | WO2006136392A3 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 03/01/2007 | WO2006133399A9 METHOD FOR PREDICTING IMMUNE RESPONSE TO NEOPLASTIC DISEASE BASED ON mRNA EXPRESSION PROFILE IN NEOPLASTIC CELLS AND STIMULATED LEUKOCYTES |
| 03/01/2007 | WO2006132983A3 Differential expression of molecules associated with vascular disease risk |
| 03/01/2007 | WO2006125437A3 Swatch for testing the washing performance of an enzyme |
| 03/01/2007 | WO2006124872A3 Methods for determining contamination of fluid compositions |
| 03/01/2007 | WO2006121710A9 Bladder cancer biomarkers and uses thereof |
| 03/01/2007 | WO2006110589A8 Gammaretrovirus associated with cancer |
| 03/01/2007 | WO2006110264A3 Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures |
| 03/01/2007 | WO2006105329A3 Device for evaluating in vitro cell migration under flow conditions, and methods of use thereof |
| 03/01/2007 | WO2006099421A3 Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
| 03/01/2007 | WO2006092795A3 Oligoribonucleotides and methods of use thereof for treatment of ocular scarring and other fibrotic conditions |
| 03/01/2007 | WO2006088950B1 Methods and reagents for treatment and diagnosis of age-related macular degeneration |
| 03/01/2007 | WO2006086669A3 Aptamer regulated nucleic acids and uses thereof |
| 03/01/2007 | WO2006085027A3 Medium for the specific detection of resistant organisms |
| 03/01/2007 | WO2006083240A3 Microbially expressed xylanases and their use as feed additives and other uses |
| 03/01/2007 | WO2006079925A3 Oligonucleotide probes for the genomic typifying of erythrocyte systems, methods and relative diagnostic kits |
| 03/01/2007 | WO2006078660A3 Nucleic acid enzyme ligation sensor |
| 03/01/2007 | WO2006076251A3 Efficient gene suppression using a transfer rna promoter in herpes virus vectors to deliver small interference rnas |
| 03/01/2007 | WO2006074482A3 Methods and kits for strand-specific polynucleotide detection with cationic multichromophores |
| 03/01/2007 | WO2006074466A3 Synthesis of epoxide based inhibitors of cysteine proteases |
| 03/01/2007 | WO2006073442A3 Detection of nuclear weapons and fissile material aboard cargo containerships |
| 03/01/2007 | WO2006073436A3 Mass tag pcr for multiplex diagnostics |
| 03/01/2007 | WO2006072016A3 Methods for regulation of stem cells |
| 03/01/2007 | WO2006069584A3 NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs |
| 03/01/2007 | WO2006069220A3 Modified human growth hormone |
| 03/01/2007 | WO2006058185A3 Device and method for electroporation-based delivery of moecules into cells and dynamic monitoring of cell responses |
| 03/01/2007 | WO2006031181A8 Methods for identifying a patient as a candidate for treatment with a long acting beta agonist and for predicting a patient’s response to long acting beta2 agonist therapy by analysing polymorphisms in the beta2-adrenergic receptor gene |
| 03/01/2007 | WO2006020567A3 Method for diagnosing obstructive sleep apnea |
| 03/01/2007 | WO2006012646A3 Amacr cancer markers |
| 03/01/2007 | WO2006009924A3 Pfks as modifiers of the igfr pathway and methods of use |
| 03/01/2007 | WO2005119255A3 Constrained cis-diol-borate bioconjugation system |
| 03/01/2007 | WO2005111243A3 Multiplexed detection of biological agents |